Discontinued — last reported Q3 '20
Becton, Dickinson and Company Life Sciences — Goodwill, Foreign Currency Translation, Gain (Loss) increased by 50.0% to -$1.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 112.5%, from $8.00M to -$1.00M. Over 3 years (FY 2021 to FY 2025), Life Sciences — Goodwill, Foreign Currency Translation, Gain (Loss) shows a downward trend with a 81.7% CAGR.
Positive values indicate a strengthening of foreign currencies against the reporting currency, while negative values indicate a weakening.
This metric captures the impact of fluctuations in foreign exchange rates on the valuation of goodwill denominated in no...
Multinational corporations with significant international operations frequently report these adjustments as part of their comprehensive income or segment reporting.
bdx_segment_life_sciences_goodwill_foreign_currency_translation_gain_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $3.00M | $3.00M | $3.00M | $5.00M | $9.00M | -$10.00M | -$2.00M | -$1.00M | -$4.00M | $1.00M | $2.00M | -$6.00M | $8.00M | -$3.00M | -$9.00M | -$2.00M | -$1.00M |
| QoQ Change | — | — | +0.0% | +0.0% | +66.7% | +80.0% | -211.1% | +80.0% | +50.0% | -300.0% | +125.0% | +100.0% | -400.0% | +233.3% | -137.5% | -200.0% | +77.8% | +50.0% |
| YoY Change | — | — | — | — | — | +200.0% | -433.3% | -166.7% | -120.0% | +60.0% | +150.0% | +300.0% | — | +300.0% | -400.0% | -550.0% | +66.7% | -112.5% |